A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin

Biochemical and Biophysical Research Communications

Volumn 391, Issue 4, 2010, Pages 1780-1784

  Cheng, De Chun ^a   Zhong, Guo Cai ^a   Su, Ju Xiang ^a   Liu, Yan Hong ^a   Li, Yan ^a   Wang, Jia Ye ^a   Hattori, Toshio ^b   Ling, Hong ^a,c   Zhang, Feng Min ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Key Lab   (China)

Author keywords

Cell fusion; Dual reporter; Envelope; HIV 1; Thrombin

Indexed keywords

CELL RECEPTOR; FIREFLY LUCIFERASE; RENILLA LUCIFERIN 2 MONOOXYGENASE; THROMBIN; VIRUS GLYCOPROTEIN;

ACCURACY; ARTICLE; ASSAY; CELL COUNT; CELL FUSION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPORTER GENE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TARGET CELL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS STRAIN;

CELL FUSION; CELL LINE; HIV ENVELOPE PROTEIN GP160; HIV FUSION INHIBITORS; HIV-1; HUMANS; LUCIFERASES, RENILLA; MEMBRANE FUSION; RECEPTORS, HIV; THROMBIN; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; RENILLA LUCIFERASE;

EID: 74449086358     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.155     Document Type: Article

References (33)

1. Ji C., Zhang J., Cammack N., and Sankuratri S. Development of a novel dual CCR5-dependent and CXCR4-dependent cell-cell fusion assay system with inducible gp160 expression. J. Biomol. Screen 11 (2006) 65-74
2. Yi Y., Singh A., Cutilli J., and Collman R.G. Use of dual recombinant vaccinia virus vectors to assay viral glycoprotein-mediated fusion with transfection-resistant primary cell targets. Methods Mol. Biol. 269 (2004) 333-346
3. Sakamoto T., Ushijima H., Okitsu S., Suzuki E., Sakai K., Morikawa S., and Muller W.E. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene. J. Virol. Methods 114 (2003) 159-166
4. Jenkinson S., McCoy D.C., Kerner S.A., Ferris R.G., Lawrence W.K., Clay W.C., Condreay J.P., and Smith C.D. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology. J. Biomol. Screen 8 (2003) 463-470
5. Huerta L., Lamoyi E., Baez-Saldana A., and Larralde C. Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay. Cytometry 47 (2002) 100-106
6. Chiba H., Asanuma S., Okamoto M., Inokoshi J., Tanaka H., Fujita K., and Omura S. A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines-establishment and validation. J. Antibiot. (Tokyo) 54 (2001) 818-826
7. Hong Y.L., Wu L.H., Cui M., McMaster G., Hunt III S.W., and Chung F.Z. New reporter cell lines to study macrophage-tropic HIV envelope protein-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses 15 (1999) 1667-1672
8. Isaacs S.N., Yi Y., Singh A., and Collman R.G. A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases. J. Virol. Methods 81 (1999) 55-61
9. Rucker J., Doranz B.J., Edinger A.L., Long D., Berson J.F., and Doms R.W. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry. Methods Enzymol. 288 (1997) 118-133
10. Moir S., and Poulin L. Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay. AIDS Res. Hum. Retroviruses 12 (1996) 811-820
11. Nussbaum O., Broder C.C., and Berger E.A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68 (1994) 5411-5422
12. Lin G., Murphy S.L., Gaulton G.N., and Hoxie J.A. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase. J. Virol. Methods 128 (2005) 135-142
13. Takeuchi Y., McClure M.O., and Pizzato M. Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J. Virol. 82 (2008) 12585-12588
14. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., and Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46 (2002) 1896-1905
15. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
16. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., and Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72 (1998) 2855-2864
17. Naldini A., Carney D.H., Bocci V., Klimpel K.D., Asuncion M., Soares L.E., and Klimpel G.R. Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol. 147 (1993) 367-377
18. Chang M.C., Chan C.P., Wu H.L., Chen R.S., Lan W.H., Chen Y.J., and Jeng J.H. Thrombin-stimulated growth, clustering, and collagen lattice contraction of human gingival fibroblasts is associated with its protease activity. J. Periodontol. 72 (2001) 303-313
19. Ling H., Xiao P., Usami O., and Hattori T. Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion. Microb. Infect. 6 (2004) 414-420
20. Lopez-Balderas N., Huerta L., Villarreal C., Rivera-Toledo E., Sandoval G., Larralde C., and Lamoyi E. In vitro cell fusion between CD4(+) and HIV-1 Env(+) T cells generates a diversity of syncytia varying in total number, size, and cellular content. Virus Res. 123 (2007) 138-146
21. Chiba-Mizutani T., Miura H., Matsuda M., Matsuda Z., Yokomaku Y., Miyauchi K., Nishizawa M., Yamamoto N., and Sugiura W. Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs. J. Clin. Microbiol. 45 (2007) 477-487
22. Coughlin S.R. Thrombin signaling and protease-activated receptors. Nature 407 (2000) 258-264
23. Davie E.W., Fujikawa K., and Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30 (1991) 10363-10370
24. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J.T., Badimon J.J., Himber J., Riederer M.A., and Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc. Natl. Acad. Sci. USA 96 (1999) 2311-2315
25. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul. Fibrinol. 9 Suppl 1 (1998) S9-14
26. Bevilacqua M.P., and Gimbrone Jr. M.A. Inducible endothelial functions in inflammation and coagulation. Semin. Thromb. Hemost. 13 (1987) 425-433
27. Galvin S.R., and Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2 (2004) 33-42
28. Cohen M.S., Hoffman I.F., Royce R.A., Kazembe P., Dyer J.R., Daly C.C., Zimba D., Vernazza P.L., Maida M., Fiscus S.A., and Eron Jr. J.J. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 349 (1997) 1868-1873
29. Clements G.J., Price-Jones M.J., Stephens P.E., Sutton C., Schulz T.F., Clapham P.R., McKeating J.A., McClure M.O., Thomson S., Marsh M., et al. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?. AIDS Res. Hum. Retroviruses 7 (1991) 3-16
30. Papandreou M.J., and Fenouillet E. Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain. Virology 241 (1998) 163-167
31. Schulz T.F., Reeves J.D., Hoad J.G., Tailor C., Stephens P., Clements G., Ortlepp S., Page K.A., Moore J.P., and Weiss R.A. Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage. AIDS Res. Hum. Retroviruses 9 (1993) 159-166
32. Ebenbichler C., Westervelt P., Carrillo A., Henkel T., Johnson D., and Ratner L. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations. Aids 7 (1993) 639-646
33. McKeating J.A. Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture. J. Gen. Virol. 77 Pt 12 (1996) 2905-2919